Treatment of AML Relapse After Allo-HCT

With advances in allogeneic hematopoietic stem cell transplant (allo-HCT), disease relapse has replaced transplant-related mortality as the primary cause of treatment failure for patients with acute myeloid leukemia (AML). The efficacy of allo-HCT in AML is a consequence of a graft-versus-leukemia (...

Descripción completa

Detalles Bibliográficos
Autores principales: Webster, Jonathan A., Luznik, Leo, Gojo, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716583/
https://www.ncbi.nlm.nih.gov/pubmed/34976845
http://dx.doi.org/10.3389/fonc.2021.812207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716583/
https://www.ncbi.nlm.nih.gov/pubmed/34976845
http://dx.doi.org/10.3389/fonc.2021.812207

Ejemplares similares